Industry Briefs: May 14, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: May 14, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Almac has added the new PharmaWorks TF3, high-speed, large-format blister equipment, at its US headquarters in Souderton, Pennsylvania. Read More

GE Healthcare Life Sciences has completed its acquisition of Xcellerex. Read More

Molecular Profiles and GEA Process Engineering are collaborating to improve early screening of poorly water-soluble drugs and polymer compositions using the GEA Niro Drynetics single-particle spray-drying application.

Novozymes Biopharma has started to supply Novozymes Hyasis, a pharmaceutical-grade hyaluronic acid, from its recently opened facility in Tianjin, China. Read More

NSF-DBA has agreed with the Semler Research Center to expand pharmaceutical training, auditing, consulting, and testing services throughout India. Read More

People News

Cytovance Biologics has named Martin LeBlanc to its board of directors. Read More

Incline Therapeutics has appointed John Tucker as senior vice-president and chief commercial officer. Read More

Teva Pharmaceutical has appointed Michael Hayden as president of global R&D and chief scientific officer Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here